We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Karolinska Development’s portfolio company Umecrine Cognition raises MSEK 23.8 to continue clinical development of golexanolone STOCKHOLM, SWEDEN – December 19, 2024. Karolinska Development AB...
Karolinska Development’s Board of Directors appoints Ben Toogood as new Chairman STOCKHOLM, SWEDEN – December 18, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the...
Karolinska Development’s Chairman of the Board resigns at his own request STOCKHOLM, SWEDEN – December 11, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the...
Karolinska Development divests 4,6 million shares in portfolio company OssDsign STOCKHOLM, SWEDEN, December 10, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) divests 4,6 million shares...
Karolinska Development's portfolio company Modus Therapeutics initiates a phase 2 study with sevuparin for treatment of chronic kidney disease with anemia STOCKHOLM, SWEDEN – December 9...
Karolinska Development implements organizational changes for more efficient portfolio management STOCKHOLM, SWEDEN – December 2, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today...
Karolinska Development's portfolio company Modus Therapeutics secures bridge financing STOCKHOLM, SWEDEN November 19, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces...
Karolinska Development’s portfolio company Umecrine Cognition presents positive interim data from Phase 1b/2a clinical study STOCKHOLM, SWEDEN – November 18, 2024. Karolinska Development AB...
Karolinska Development's portfolio company SVF Vaccines appoints Dr Gaston Picchio as acting CEO STOCKHOLM, Sweden, 15 November 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today...
Interim Report - January-September 2024 STOCKHOLM – 15 November 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report - January-September 2024. The full...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 6.5 | 6.5 | 6.5 | 0 | 0 | DE |
4 | 0 | 0 | 6.5 | 6.5 | 6.5 | 0 | 0 | DE |
12 | 0 | 0 | 6.5 | 6.5 | 6.5 | 0 | 0 | DE |
26 | 0 | 0 | 6.5 | 6.5 | 6.5 | 0 | 0 | DE |
52 | 0 | 0 | 6.5 | 6.5 | 6.5 | 207 | 6.5 | DE |
156 | 0 | 0 | 6.5 | 6.5 | 6.5 | 597 | 6.5 | DE |
260 | 0 | 0 | 6.5 | 6.5 | 6.5 | 629 | 6.5 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions